Brief: Hemogenyx Pharma Gets USFDA Full Review Letter On INDA For Candidate Chimeric Antigen Receptor T-Cells

Hemogenyx Pharmaceuticals

10/07/2023 07:32

July 10 (Reuters) - Hemogenyx Pharmaceuticals PLC
 HEMO.L :
    * HEMOGENYX PHARMA PLC  - FULL FDA REVIEW FOR HEMO-CAR-T IND
    * HEMOGENYX PHARMA - RECEIVED FULL REVIEW LETTER FROM FDA
REGARDING INVESTIGATIONAL NEW DRUG APPLICATION FOR CANDIDATE
CHIMERIC ANTIGEN RECEPTOR T-CELLS

Source text for Eikon:  ID:nRSJ4200Fa 
Further company coverage:  HEMO.L 

 ((Reuters.Briefs@thomsonreuters.com;))